MENINGIOMA
Clinical trials for MENINGIOMA explained in plain language.
Never miss a new study
Get alerted when new MENINGIOMA trials appear
Sign up with your email to follow new studies for MENINGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising targeted therapy for tough brain cancers moves forward
Disease control Recruiting nowThis study is testing a drug called Lutathera in children and young adults (ages 4 to 39) whose brain tumors have come back or are growing despite treatment. The drug delivers radiation directly to tumor cells that show up on a special PET scan. The goal is to find the safest dos…
Matched conditions: MENINGIOMA
Phase: PHASE1, PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Jun 22, 2026 12:03 UTC
-
New drug combo offers hope for kids with Tough-to-Treat cancers
Disease control Recruiting nowThis study is for children and teens (ages 3 to 18) with certain solid tumors that have returned or not responded to standard treatment. The tumors must have a specific marker called SSTR. The study combines two drugs: Lutathera (a radioactive drug that targets SSTR) and Olaparib…
Matched conditions: MENINGIOMA
Phase: PHASE1, PHASE2 • Sponsor: Fundación de investigación HM • Aim: Disease control
Last updated Jun 22, 2026 12:03 UTC
-
Could a cancer pill slow aggressive brain tumors?
Disease control Recruiting nowThis study tests whether the drug abemaciclib can help people with a fast-growing type of brain tumor called grade 3 meningioma. Participants will receive either the drug or a placebo after standard radiation therapy. The goal is to see if the drug delays tumor growth. About 72 p…
Matched conditions: MENINGIOMA
Phase: PHASE2 • Sponsor: Nader Sanai • Aim: Disease control
Last updated Jun 18, 2026 11:52 UTC
-
Brain cancer survivors: can a home program boost your memory?
Symptom relief Recruiting nowThis study tests a home-based program called HOBSCOTCH-CA for brain cancer survivors who struggle with memory and thinking. The program involves weekly virtual sessions with a coach, teaching problem-solving and relaxation techniques. Researchers will compare two groups: one that…
Matched conditions: MENINGIOMA
Phase: NA • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Symptom relief
Last updated Jun 23, 2026 20:32 UTC